Zaire Ebola Vaccine Shows Promise Against Bundibugyo Outbreak

A licensed vaccine developed for Zaire ebolavirus may offer partial protection against Bundibugyo ebolavirus, which currently lacks approved therapeutics or vaccines. Bundibugyo ebolavirus is responsible for the largest documented outbreak of this species in the Democratic Republic of the Congo and Uganda. With no specific treatments available, cross-protection from the Zaire vaccine represents a critical tool for outbreak control. This finding underscores the urgent need for dedicated medical countermeasures against lesser-known but equally dangerous ebolavirus species.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: July 25, 2026 at 10:03 AM



